Radiation to treat a few metastatic spots in rare cancers
Part of Cancer, Digestive system, Hormones & metabolism, Kidney & urinary, Skin, Women’s health & pregnancy clinical trials.
This trial studies whether stereotactic (high-precision) radiation given in a few sessions can control rare cancers that have spread to a small number of sites. It aims to help by treating all known spots while keeping side effects manageable.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a confirmed cancer that has spread to imaging, and your main cancer is under control
- You have 1 to 5 metastatic spots (called oligometastases) that can be treated safely with radiation
- If you have brain metastases, they must be treatable with stereotactic radiation or surgery has already been done
- You are 18 or older, and you can expect to live more than 6 months
- Your overall health is good enough for treatment (ECOG 0 to 2) and you can sign consent
- Your cancer type is not prostate, breast, lung, or colorectal
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a faster way to give radiation to people with a few spots of cancer that have spread. They use a special scan to plan treatment right away, so you may not need a separate planning visit.
This trial tests whether a precise type of radiation can control cancer that has spread to a limited number of sites (1–10) while you also have the main tumor. It aims to improve outcomes by treating all visible cancer spots with stereotactic ablative radiotherapy.
This trial looks at whether a precise form of radiation (stereotactic body radiotherapy) can control a small number of prostate cancer spots seen on a special scan (PSMA PET/CT). It may help by treating limited metastases while avoiding unnecessary treatment elsewhere.
This trial tests whether high-precision radiation (SBRT) can improve outcomes for people with up to 5 small, stable metastases from certain cancers, compared to usual palliative care. It is for those whose disease is not growing after current chemotherapy.
This trial tests a precise type of radiation that targets multiple tumor spots in a carefully planned way. It may help people with many metastatic (spread) solid tumors when standard treatments aren’t working or can’t be used.
This trial tests powerful, precisely aimed radiation (MR-guided stereotactic body radiation therapy) in a single session to treat 1 to 3 small metastatic tumors outside the brain and spine. It aims to control cancer growth with fewer visits and less impact on healthy tissue.
Hear when a new Gynecologic Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.